Email Updates

Search form

You are here

AVAC's Blog: P-Values

  • AMP. Licensure. Enrollment targets. Success. These were the buzz words from the HIV Vaccine Trials Network regional meeting last month, highlighting the HVTN’s build out of programs in sub-Saharan Africa and the significance of an HIV vaccine for this region.

    March 21, 2017
    Ruth Assefa
    Stacey Hannah
  • We've posted several new resources on AVAC.org that you won’t want to miss—analysis of the WHO's recently released guidance on the use of hormonal contraceptives in women at risk of HIV, information about time to protection for PrEP and a blog on building solidarity between African American gay men and African gay men through PrEP.

    March 20, 2017
    General
    AVAC
  • Despite decades of advances in HIV prevention, HIV continues to burden gay and bisexual men disproportionately, especially younger gay men, and men who have sex with men. This is truly a global health issue—applying equally to the US and to Africa. Vulnerability to HIV exposure is propelled by key structural drivers: antigay stigma laws, poverty and inadequate understanding of how to prevent HIV.

    March 17, 2017
    General
    Micheal Ighodaro
  • How many doses of oral PrEP must be taken to build up protective levels of drug in the blood? Join us for a webinar where representatives from the CDC and WHO will review their respective guidance development processes and the role, use, contexts and audience for guidance documents.

    March 16, 2017
    AVAC
  • The WHO issued an updated guidance statement on its recommendations for the use of hormonal contraception by women at high risk of HIV. The update changes the WHO classification of long-acting injectable contraceptives. WHO states “there continues to be evidence of a possible increased risk of HIV among progestogen-only injectable users.” The new guidance is clear that the recommendations are based on women’s right to informed choice in health.

    March 2, 2017
    AVAC
  • AVAC Staffer Micheal Ighodaro reflects on the atmosphere at the National African American MSM Leadership Conference which took place the week of the Presidential Inauguration.
    February 24, 2017
    General, PrEP
    Micheal Ighodaro
  • The annual Conference on Retroviruses and Opportunistic Infections (CROI) is kicking off in Seattle. This year’s program covers a range of topics of interest to advocates including new data on basic science, a look at clinical trial design, planning to end the epidemic in New York, applying good participatory practices in research, understanding HIV and substance use and more.

    February 10, 2017
    General
    AVAC
  • There has been lots of discussion about the different PrEP guidelines with respect to how long it takes women to get protection with oral PrEP. This webinar included pharmacologists who have studied drug levels in the blood and tissue of PrEP users, followed by a question and answer period.

    February 7, 2017
    AVAC
  • AVAC is delighted to announce the 2017 AVAC Advocacy Fellows—the eighth class of Fellows selected from a pool of over 100 applicants from 20 countries in Africa, Asia and the Caribbean. Please join us in congratulating these seven talented advocates.

    February 2, 2017
    General
    AVAC
  • AVAC.org has a host of new resources providing concise updates, informed perspective and handy tools. Take a look at the highlights below and get up to speed on a range of strategic issues.

    January 31, 2017
    Antibody Related Research, HIV Vaccine, General, PrEP, Treatment
    AVAC

Pages